Veratox® for Neomycin is a competitive enzyme immunoassay for the quantitative analysis of Neomycin in muscle. Veratox for Neomycin enables international and government regulatory agencies, food manufacturers and processors, as well as quality assurance organizations, to detect neomycin in various sample types and to satisfy customer concerns about food safety.
Specifications
Analyte Neomycin
Brand Veratox®
Package Dimensions 5.30 IN x 3.50 IN x 1.10 IN
Package Weight 0.80 LB
Platform ELISA
Quantity per Package 36 tests
Range of Detection 75.00 ppb - 1,875.00 ppb
Result Type Quantitative
Testing Time 60.00 - 120.00 Minutes
Time to Result 45 Minutes

  1. Neomycin-coated Plate 1 x 96-well plate (8 wells x 12 strips)
  2. Neomycin Standards:
    • 0 ng/mL (white cap tube) 0.8 mL
    • 3.0 ng/mL (yellow cap tube) 0.8 mL
    • 7.5 ng/mL (orange cap tube) 0.8 mL
    • 15 ng/mL (pink cap tube) 0.8 mL
    • 30 ng/mL (purple cap tube) 0.8 mL
    • 75 ng/mL (blue cap tube) 0.8 mL
    • 10,000 ng/mL (spiking, red cap tube) 0.8 mL
  3. Neomycin Antibody #1 (powder) 3 tubes
  4. 100X HRP-Conjugated Antibody #2 125 μL
  5. 20X Wash Solution 28 mL
  6. Stop Buffer 14 mL
  7. TMB Substrate 12 mL
  8. 10X Sample Extraction Buffer 25 mL
  9. 10X Neomycin Extraction Buffer I 28 mL
  10. 2X Neomycin Extraction Buffer II 28 mL
  1. Microtiter plate reader with a 450 nm filter (Neogen item 9303)
  2. Tissue Mixer
  3. Vortex Mixer (Neogen 9494)
  4. 20–200 μL pipettes (Neogen item 9276)
  5. Multichannel pipette: 50–300 μL (optional) (Neogen item 9385)
  6. 1000 μL pipettor (Neogen 9337)
  7. n-Hexane
  8. Centrifuge 4,000 x g
  9. Timer (Neogen item 9426)
  10. Wash bottle (Neogen item 9400)
  11. Paper towels or equivalent absorbent material
  12. Veratox software (Neogen item 9305)
  13. Lab station (Neogen item 9481)
  14. Distilled or deionized water
  15. Blender or food processor to homogenize sample

The method is based on a competitive colorimetric ELISA assay. The drug of interest has been coated in the plate wells. During the analysis, sample is added along with the enzyme-conjugate and the primary antibody specific for the target drug. If the target is present in the sample, it will compete for the antibody, thereby preventing the antibody from binding to the drug attached to the well. The enzyme-conjugate will bind with the primary antibody that is complexed to the drug coated on the plate wells. The resulting color intensity, after addition of substrate, has an inverse relationship with the target concentration in the sample.

Training

Our customers’ success is our shared success. Our experts are ready to train you and your team on our solutions, so you can rest easy knowing procedures are performed properly and yield accurate results. In addition, we provide certificates upon completion of training to provide you with the documentation needed for audit traceability.


Support

Validation

Our experts are here to help. If you need information beyond what is provided in Validation Reports under the Documents tab, please contact us and we will be happy to assist you. Learn more